Federal Statute and Guidance | Covid-19 | Aug 25, 2020
CDC Issues Interim Guidance for Rapid Antigen Testing for SARS-CoV-2
CDC issued interim guidance for clinicians who order antigen tests, receive antigen test results, and/or perform point-of-care testing, as well as for laboratory professionals who perform antigen testing in a laboratory setting or at the point of care and report those results. CDC indicated its guidance is intended to support the effective use of antigen tests for various testing situations. This guidance applies to all uses of antigen tests and is not specific to the application of antigen tests to any particular age group or setting. The guidance also outlines the regulatory requirements for using rapid antigen tests for SARS-CoV-2 for the purposes of diagnostic and surveillance testing.